Skip to main content
Caplight Logo









perkinelmer

perkinelmer

Private

Last Round

M&A

Mar 13, 2023

Last Round Size

$2.45B

Est. Valuation

$2.45B

Total Funding Raised

$2.45B

Company Overview

PerkinElmer is a life sciences and diagnostics company that offers a wide range of instruments, tests, services, and software solutions for the pharmaceutical, biomedical, chemical, environmental, and industrial markets.

Sector

Biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

perkinelmer Comparables

Compare perkinelmer with similar companies based on industry and business-model similarity.

No public comparables are available for perkinelmer. Request access to learn about comparables coverage.

Book a demo

For institutional investors. Book with your work email.

perkinelmer Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMar 13, 2023
Book a demo to see this round

For institutional investors. Book with your work email.

perkinelmer Filings

Explore SEC and related filing metadata, where available.

perkinelmer filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—
Year Founded1937
Last FundingMar 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?